6.74

2.88% -0.20

Compass Pathways Plc Adr (CMPS)

Overview News Price History Option Chain Financials Discussions Forecast

Compass Pathways Plc Adr stock is traded at $6.74, with a volume of 1.35M. It is down -2.88% in the last 24 hours and up +15.02% over the past month. Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Previous Close:

$6.94

Open:

$7.01

24h Volume:

1.35M

Relative Volume:

0.78

Market Cap:

$647.15M

Revenue:

Net Income/Loss:

$-144.32M

P/E Ratio:

-3.0917

EPS:

-2.18

Net Cash Flow:

$-105.21M

1W Performance:

+15.81%

1M Performance:

+15.02%

6M Performance:

+49.12%

1Y Performance:

+52.83%

1-Day Range:

$6.69

$7.13

1-Week Range:

$5.78

$7.13

52-Week Range:

$2.25

$7.13

Compass Pathways Plc Adr Stock (CMPS) Company Profile

Name

Compass Pathways Plc Adr

Sector

Healthcare (1123)

Industry

Medical Care Facilities (54)

Phone

1-716-676-6461

Address

3RD FLOOR, 1 ASHLEY ROAD, CHESIRE

Employee

166

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

CMPS's Discussions on Twitter

Compare CMPS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CMPS Compass Pathways Plc Adr	6.74	666.36M	0	-144.32M	-105.21M	-2.18
HCA Hca Healthcare Inc	484.77	110.07B	74.37B	7.31B	8.10B	25.88
THC Tenet Healthcare Corp	199.40	17.38B	20.69B	2.40B	1.55B	15.62
UHS Universal Health Services Inc	222.60	14.03B	16.08B	1.20B	1.06B	17.82
FMS Fresenius Medical Care Ag Adr	23.60	13.55B	21.23B	924.30M	2.22B	1.2272
EHC Encompass Health Corp	107.00	10.75B	5.51B	494.70M	386.40M	4.84

Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-10-25	Upgrade	Oppenheimer	Perform → Outperform
Jun-23-25	Downgrade	Evercore ISI	Outperform → In-line
Feb-27-25	Initiated	Stifel	Buy
Jul-23-24	Initiated	RBC Capital Mkts	Outperform
Apr-01-24	Initiated	Morgan Stanley	Overweight
Dec-12-23	Initiated	Deutsche Bank	Buy
Nov-21-22	Resumed	Berenberg	Buy
Nov-01-22	Initiated	Loop Capital	Buy
Oct-29-21	Initiated	Oppenheimer	Outperform
Jul-13-21	Initiated	Citigroup	Buy
Jun-28-21	Initiated	Maxim Group	Buy
May-11-21	Initiated	Cantor Fitzgerald	Overweight
Apr-01-21	Initiated	ROTH Capital	Buy
Oct-14-20	Initiated	H.C. Wainwright	Buy
Oct-13-20	Initiated	Berenberg	Buy
Oct-13-20	Initiated	Canaccord Genuity	Buy
Oct-13-20	Initiated	Cowen	Outperform
Oct-13-20	Initiated	Evercore ISI	Outperform

View All

Compass Pathways Plc Adr Stock (CMPS) Latest News

Dec 13, 2025

COMPASS Pathways (NASDAQ:CMPS) Reaches New 12-Month HighShould You Buy? - MarketBeat

Dec 13, 2025

Dec 10, 2025

COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpWhat's Next? - MarketBeat

Dec 10, 2025

Healthy Upside Potential: Compass Pathways Plc ADR (CMPS) - setenews.com

Dec 10, 2025

Dec 08, 2025

COMPASS Pathways PLC Sponsored ADR $CMPS Position Boosted by 22NW LP - MarketBeat

Dec 08, 2025

Dec 07, 2025

Schroder Investment Management Group Makes New $1.53 Million Investment in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat

Dec 07, 2025

Dec 06, 2025

1,075,485 Shares in COMPASS Pathways PLC Sponsored ADR $CMPS Purchased by Hsbc Holdings PLC - MarketBeat

Dec 06, 2025

Dec 05, 2025

COMPASS Pathways (NASDAQ:CMPS) Trading 10.7% HigherWhat's Next? - MarketBeat

Dec 05, 2025

COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 05, 2025

COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Dec 05, 2025

Dec 02, 2025

Prepare Yourself for Liftoff: Compass Pathways Plc ADR (CMPS) - Setenews

Dec 02, 2025

Nov 28, 2025

Compass Pathways Stock: Navigating Volatility in Psychedelic Medicine () - aktiencheck.de

Nov 28, 2025

Nov 25, 2025

Ready to Jump After Recent Trade: Triller Group Inc (ILLR) - Setenews

Nov 25, 2025

Nov 18, 2025

Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews

Nov 18, 2025

Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World

Nov 18, 2025

Nov 15, 2025

Discontinued operations of COMPASS Pathways Plc Sponsored ADR – HAM:5Y6 - TradingView

Nov 15, 2025

COMPASS Pathways Plc Sponsored ADR Trade Ideas — HAM:5Y6 - TradingView

Nov 15, 2025

Nov 11, 2025

The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews

Nov 11, 2025

Nov 10, 2025

Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView

Nov 10, 2025

Nov 05, 2025

This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews

Nov 05, 2025

Nov 04, 2025

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se

Nov 04, 2025

Nov 01, 2025

Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World

Nov 01, 2025

Oct 30, 2025

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com

Oct 30, 2025

Oct 29, 2025

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA

Oct 29, 2025

Oct 28, 2025

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com

Oct 28, 2025

Oct 23, 2025

ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat

Oct 23, 2025

Oct 16, 2025

Compass Pathways soars 62% after December Fair Value signal - Investing.com

Oct 16, 2025

Oct 15, 2025

Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development (CMPS) - Seeking Alpha

Oct 15, 2025

COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World

Oct 15, 2025

Oct 14, 2025

COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World

Oct 14, 2025

COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat

Oct 14, 2025

Oct 08, 2025